• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰十二指肠切除术后胰头导管腺癌患者的预后列线图

Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy.

作者信息

Zhuang Hongkai, Zhou Zixuan, Ma Zuyi, Huang Shanzhou, Gong Yuanfeng, Li Zhenchong, Liu Chunsheng, Wang Shujie, Chen Bo, Zhang Chuanzhao, Hou Baohua

机构信息

Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

Shantou University of Medical College, Shantou, China.

出版信息

Clin Med Insights Oncol. 2021 Jun 18;15:11795549211024149. doi: 10.1177/11795549211024149. eCollection 2021.

DOI:10.1177/11795549211024149
PMID:34211308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8216341/
Abstract

BACKGROUND

The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) of pancreatic head remains poor, even after potentially curative R0 resection. The aim of this study was to develop an accurate model to predict patients' prognosis for PDAC of pancreatic head following pancreaticoduodenectomy.

METHODS

We retrospectively reviewed 112 patients with PDAC of pancreatic head after pancreaticoduodenectomy in Guangdong Provincial People's Hospital between 2014 and 2018.

RESULTS

Five prognostic factors were identified using univariate Cox regression analysis, including age, histologic grade, American Joint Committee on Cancer (AJCC) Stage 8th, total bilirubin (TBIL), CA19-9. Using all subset analysis and multivariate Cox regression analysis, we developed a nomogram consisted of age, AJCC Stage 8th, perineural invasion, TBIL, and CA19-9, which had higher C-indexes for OS (0.73) and RFS (0.69) compared with AJCC Stage 8th alone (OS: 0.66; RFS: 0.67). The area under the curve (AUC) values of the receiver operating characteristic (ROC) curve for the nomogram for OS and RFS were significantly higher than other single parameter, which are AJCC Stage 8th, age, perineural invasion, TBIL, and CA19-9. Importantly, our nomogram displayed higher C-index for OS than previous reported models, indicating a better predictive value of our model.

CONCLUSIONS

A simple and practical nomogram for patient prognosis in PDAC of pancreatic head following pancreaticoduodenectomy was established, which shows satisfactory predictive efficacy and deserves further evaluation in the future.

摘要

背景

即使在进行了可能治愈性的R0切除术后,胰头导管腺癌(PDAC)患者的预后仍然很差。本研究的目的是建立一个准确的模型来预测胰十二指肠切除术后胰头PDAC患者的预后。

方法

我们回顾性分析了2014年至2018年期间在广东省人民医院接受胰十二指肠切除术后的112例胰头PDAC患者。

结果

通过单因素Cox回归分析确定了五个预后因素,包括年龄、组织学分级、美国癌症联合委员会(AJCC)第8版分期、总胆红素(TBIL)、CA19-9。通过全子集分析和多因素Cox回归分析,我们建立了一个由年龄、AJCC第8版分期、神经周围侵犯、TBIL和CA19-9组成的列线图,与单独的AJCC第8版分期相比,该列线图的总生存期(OS)C指数为0.73,无复发生存期(RFS)C指数为0.69(OS:0.66;RFS:0.67)。该列线图的OS和RFS的受试者操作特征(ROC)曲线下面积(AUC)值显著高于其他单一参数,即AJCC第8版分期、年龄、神经周围侵犯、TBIL和CA19-9。重要的是,我们的列线图显示的OS C指数高于先前报道的模型,表明我们的模型具有更好的预测价值。

结论

建立了一个简单实用的胰十二指肠切除术后胰头PDAC患者预后列线图,其显示出令人满意的预测效果,值得未来进一步评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/328d/8216341/4f2748ea5a74/10.1177_11795549211024149-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/328d/8216341/2966bd5cf4c2/10.1177_11795549211024149-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/328d/8216341/18ee977be990/10.1177_11795549211024149-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/328d/8216341/d82106a2d40d/10.1177_11795549211024149-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/328d/8216341/4f2748ea5a74/10.1177_11795549211024149-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/328d/8216341/2966bd5cf4c2/10.1177_11795549211024149-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/328d/8216341/18ee977be990/10.1177_11795549211024149-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/328d/8216341/d82106a2d40d/10.1177_11795549211024149-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/328d/8216341/4f2748ea5a74/10.1177_11795549211024149-fig4.jpg

相似文献

1
Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy.胰十二指肠切除术后胰头导管腺癌患者的预后列线图
Clin Med Insights Oncol. 2021 Jun 18;15:11795549211024149. doi: 10.1177/11795549211024149. eCollection 2021.
2
Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.机器人辅助胰十二指肠切除术治疗胰腺导管腺癌:高容量中心的手术结果及长期预后分析
Hepatobiliary Pancreat Dis Int. 2023 Apr;22(2):140-146. doi: 10.1016/j.hbpd.2022.09.006. Epub 2022 Sep 20.
3
A prognostic nomogram for pancreatic ductal adenocarcinoma patients' all-cause survival in a Surveillance, Epidemiology, and End Results analysis.在监测、流行病学和最终结果分析中,用于预测胰腺导管腺癌患者全因生存率的预后列线图。
Transl Cancer Res. 2020 May;9(5):3586-3599. doi: 10.21037/tcr-19-2962.
4
Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram-based prediction.术后中性粒细胞与淋巴细胞比值对开放性远端胰腺脾切除术治疗胰腺导管腺癌患者生存的独立影响及其基于列线图的预测
J Cancer. 2019 Oct 15;10(24):5935-5943. doi: 10.7150/jca.35856. eCollection 2019.
5
Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.头颈部腺癌患者行根治性胰十二指肠切除术的预后列线图。
BMC Cancer. 2021 May 27;21(1):624. doi: 10.1186/s12885-021-08295-5.
6
Effects of Total Pancreatectomy on Survival of Patients With Pancreatic Ductal Adenocarcinoma: A Population-Based Study.全胰切除术对胰腺导管腺癌患者生存的影响:一项基于人群的研究
Front Surg. 2021 Dec 9;8:804785. doi: 10.3389/fsurg.2021.804785. eCollection 2021.
7
A Prognostic Nomogram for Disease-Specific Survival in Patients with Pancreatic Ductal Adenocarcinoma of the Head of the Pancreas Following Pancreaticoduodenectomy.胰头十二指肠切除术后胰头导管腺癌患者的疾病特异性生存预后列线图
Med Sci Monit. 2018 Sep 10;24:6313-6321. doi: 10.12659/MSM.909649.
8
A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.基于术前炎症标志物预测胰腺导管腺癌总生存期的列线图。
J Gastroenterol Hepatol. 2017 Jul;32(7):1394-1402. doi: 10.1111/jgh.13676.
9
The enigmatic helicase DHX9 as a candidate prognostic biomarker for resected pancreatic ductal adenocarcinoma.神秘的解旋酶DHX9作为切除性胰腺导管腺癌的候选预后生物标志物。
Front Oncol. 2022 Dec 12;12:1066717. doi: 10.3389/fonc.2022.1066717. eCollection 2022.
10
Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection.碱性磷酸酶与白蛋白比值作为胰导管腺癌根治性切除术后的预后指标
J Cancer. 2017 Sep 20;8(16):3362-3370. doi: 10.7150/jca.20917. eCollection 2017.

引用本文的文献

1
Correlation between pre-treatment serum total blood bilirubin and unconjugated bilirubin and prognosis in patients with colorectal cancer.结直肠癌患者治疗前血清总胆红素和非结合胆红素与预后的相关性
World J Gastrointest Surg. 2023 Nov 27;15(11):2456-2462. doi: 10.4240/wjgs.v15.i11.2456.

本文引用的文献

1
Clinical Significance of Preoperative Albumin-Bilirubin Grade in Pancreatic Cancer.术前白蛋白-胆红素分级在胰腺癌中的临床意义。
Ann Surg Oncol. 2021 Oct;28(11):6223-6235. doi: 10.1245/s10434-021-09593-9. Epub 2021 Jan 23.
2
Prognostic and predictive factors in pancreatic cancer.胰腺癌的预后因素和预测因素。
Oncotarget. 2020 Mar 10;11(10):924-941. doi: 10.18632/oncotarget.27518.
3
Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma.
开发和验证用于预测胰腺导管腺癌患者手术后生存的新型列线图。
Cancer Med. 2020 May;9(10):3353-3370. doi: 10.1002/cam4.2959. Epub 2020 Mar 17.
4
Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma.神经周围浸润通过胰腺导管腺癌中的胆碱能信号转导重新编程免疫微环境。
Cancer Res. 2020 May 15;80(10):1991-2003. doi: 10.1158/0008-5472.CAN-19-2689. Epub 2020 Feb 25.
5
Progress in Animal Models of Pancreatic Ductal Adenocarcinoma.胰腺导管腺癌动物模型的研究进展
J Cancer. 2020 Jan 14;11(6):1555-1567. doi: 10.7150/jca.37529. eCollection 2020.
6
[Current research status and progress in comprehensive diagnosis and treatment of pancreatic cancer in the era of targeted therapy].[靶向治疗时代胰腺癌综合诊疗的研究现状与进展]
Zhonghua Wai Ke Za Zhi. 2020 Jan 1;58(1):22-26. doi: 10.3760/cma.j.issn.0529-5815.2020.01.006.
7
Superior mesenteric artery first approach can improve the clinical outcomes of pancreaticoduodenectomy: A meta-analysis.肠系膜上动脉优先入路可改善胰十二指肠切除术的临床结局:一项荟萃分析。
Int J Surg. 2020 Jan;73:14-24. doi: 10.1016/j.ijsu.2019.11.007. Epub 2019 Nov 18.
8
Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal Adenocarcinoma.多组学数据的生存分析确定胰腺导管腺癌的潜在预后标志物
Front Genet. 2019 Jul 18;10:624. doi: 10.3389/fgene.2019.00624. eCollection 2019.
9
Development and validation of a nomogram to predict liver metastasis in patients with pancreatic ductal adenocarcinoma: a large cohort study.预测胰腺导管腺癌患者肝转移的列线图的开发与验证:一项大型队列研究
Cancer Manag Res. 2019 May 2;11:3981-3991. doi: 10.2147/CMAR.S200684. eCollection 2019.
10
A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.转移性胰腺导管腺癌患者的竞争风险列线图
Med Sci Monit. 2019 May 18;25:3683-3691. doi: 10.12659/MSM.913533.